The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-4-((3-(3-(hexyloxy)phenyl)propyl)amino)-2-hydroxy-4-oxobut-2-enoic acid ID: ALA2063255
Max Phase: Preclinical
Molecular Formula: C19H27NO5
Molecular Weight: 349.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCOc1cccc(CCCNC(=O)/C=C(\O)C(=O)O)c1
Standard InChI: InChI=1S/C19H27NO5/c1-2-3-4-5-12-25-16-10-6-8-15(13-16)9-7-11-20-18(22)14-17(21)19(23)24/h6,8,10,13-14,21H,2-5,7,9,11-12H2,1H3,(H,20,22)(H,23,24)/b17-14-
Standard InChI Key: LTXZSLKTHFHDTP-VKAVYKQESA-N
Molfile:
RDKit 2D
25 25 0 0 0 0 0 0 0 0999 V2000
11.3839 -6.3701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3837 -7.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0988 -7.6025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8127 -7.1872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8070 -6.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0912 -5.9520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5184 -5.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2359 -6.3476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9473 -5.9299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6648 -6.3371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3762 -5.9194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3702 -5.0945 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0937 -6.3267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8051 -5.9090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5226 -6.3163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7991 -5.0840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5307 -7.1435 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2361 -5.9008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6674 -5.9612 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.9550 -6.3772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2385 -5.9683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5261 -6.3844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8095 -5.9754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0971 -6.3915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3806 -5.9826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 1 1 0
11 13 1 0
1 2 2 0
13 14 2 0
5 7 1 0
14 15 1 0
3 4 2 0
14 16 1 0
7 8 1 0
15 17 1 0
15 18 2 0
8 9 1 0
1 19 1 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 1 0
2 3 1 0
21 22 1 0
10 11 1 0
22 23 1 0
5 6 2 0
23 24 1 0
11 12 2 0
24 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 349.43Molecular Weight (Monoisotopic): 349.1889AlogP: 3.22#Rotatable Bonds: 12Polar Surface Area: 95.86Molecular Species: ACIDHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.76CX Basic pKa: ┄CX LogP: 3.37CX LogD: -0.13Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.31Np Likeness Score: -0.16
References 1. Zhang Y, Fu-Yang Lin, Li K, Zhu W, Liu YL, Cao R, Pang R, Lee E, Axelson J, Hensler M, Wang K, Molohon KJ, Wang Y, Mitchell DA, Nizet V, Oldfield E.. (2012) HIV-1 Integrase Inhibitor-Inspired Antibacterials Targeting Isoprenoid Biosynthesis., 3 (5): [PMID:22662288 ] [10.1021/ml300038t ]